Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-34.30M
Near historical average
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-35.76M
Historical baseline
PeriodValueYoY Change
2025$-34.30M+36.0%
2024$-53.63M+26.4%
2023$-72.89M-143.6%
2022$-29.92M+14.8%
2021$-35.12M-28.9%
2020$-27.26M+47.5%
2019$-51.87M-119.7%
2018$-23.61M-230.9%
2017$-7.14M+67.4%
2016$-21.89M-